Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment

医学 肿瘤微环境 新辅助治疗 肿瘤科 化疗 免疫系统 免疫疗法 内科学 免疫检查点 癌症 免疫学 乳腺癌
作者
Xiaoyuan Wang,Xiaodong Ling,Changhong Wang,Jinfeng Zhang,Jing Wang,Hao Jiang,Yanzhong Xin,Luquan Zhang,Hao Liang,Chengyuan Fang,Dayong Zheng,Jinhong Zhu,Jianqun Ma
出处
期刊:Cancer Immunology, Immunotherapy [Springer Science+Business Media]
卷期号:72 (6): 1619-1631 被引量:6
标识
DOI:10.1007/s00262-022-03354-7
摘要

Immune checkpoint inhibitors (ICIs) through programmed cell death 1 blockade improve the survival outcomes of patients with advanced esophageal squamous cell carcinoma (ESCC). Recently, the use of neoadjuvant immunotherapy for the treatment of ESCC has been gradually increasing. We aimed to evaluate the efficacy of neoadjuvant treatment of ICIs with chemotherapy and explore tumor microenvironment (TME) immune profiles of ESCC samples during neoadjuvant therapy. Patients with previously untreated, resectable, locally advanced ESCC (stage II or III) in Harbin Medical University Cancer Hospital were enrolled. Each patient received two to four cycles of neoadjuvant ICIs combined with chemotherapy before surgical resection. The TME immune profiles of formalin-fixed paraffin-embedded tumor samples at baseline and after surgery were evaluated by multiplex staining and multispectral imaging. In all, 18 patients were enrolled, and all patients received surgery with R0 resection. The postoperative pathological evaluation indicated that 7 (38.9%) patients had a pathological complete response (pCR) and 11 (61.1%) patients had a partial response. The neoadjuvant therapeutic regimens had acceptable side effect profiles. The TME immune profiles at baseline observed higher densities of stroma CD3 + , PD-1 + , and PD-1 + CD3 + cells in pCR patients than in non-pCR patients. Comparing TME immune profiles before and after neoadjuvant treatment, an increase in CD8 + T cells and a decrease in CD163 + CD68 + M2-like macrophage cells were observed after neoadjuvant treatment. Neoadjuvant ICIs combined with chemotherapy produced a satisfactory treatment response, demonstrating its anti-tumor efficacy in locally advanced ESCC. Further large-scale studies are required to understand the role of tumor immunities and ICIs underlying ESCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
丰富的柠檬完成签到 ,获得积分10
刚刚
刚刚
1秒前
1秒前
风吹麦浪的应助被布公采纳,获得10
1秒前
MMM完成签到,获得积分20
1秒前
2秒前
2秒前
huhuiya发布了新的文献求助10
2秒前
2秒前
3秒前
cwp发布了新的文献求助10
3秒前
wwww发布了新的文献求助10
3秒前
3秒前
顺心的老五完成签到,获得积分10
3秒前
3秒前
nanke完成签到,获得积分10
3秒前
GamAooL完成签到,获得积分10
3秒前
3秒前
远方发布了新的文献求助10
4秒前
qianwen完成签到,获得积分10
4秒前
于小野完成签到,获得积分10
4秒前
虚幻的若雁完成签到,获得积分10
4秒前
4秒前
4秒前
远方发布了新的文献求助10
5秒前
远方发布了新的文献求助10
5秒前
Akim的应助被前行的灿采纳,获得10
5秒前
Owen的应助被科研通管家采纳,获得10
5秒前
远方发布了新的文献求助10
5秒前
DW的应助被Liu采纳,获得10
5秒前
远方发布了新的文献求助10
5秒前
丘比特的应助被科研通管家采纳,获得10
5秒前
远方发布了新的文献求助10
5秒前
甜甜沛岚完成签到 ,获得积分10
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
远方发布了新的文献求助10
5秒前
远方发布了新的文献求助10
5秒前
JamesPei的应助被科研通管家采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315